#44 - Joerg Ahlgrimm, CEO at SK Pharmteco
Impossible d'ajouter des articles
Désolé, nous ne sommes pas en mesure d'ajouter l'article car votre panier est déjà plein.
Veuillez réessayer plus tard
Veuillez réessayer plus tard
Échec de l’élimination de la liste d'envies.
Veuillez réessayer plus tard
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
#44 - Joerg Ahlgrimm, CEO at SK Pharmteco
-
Lu par :
-
De :
À propos de ce contenu audio
Join us on the latest episode! Our Guest: Joerg Ahlgrimm, CEO at SK Pharmteco.
What you'll get out of this episode:
- Joerg Ahlgrimm discusses his journey in the pharmaceutical industry and his role at SK Pharmteco.
- The strategic integration of companies under SK Pharmteco to enhance global CDMO capabilities.
- The importance of a patient-centric approach in driving company success and innovation.
- Challenges and strategies for ensuring operational efficiency and overcoming funding difficulties in biotech.
- Ahlgrimm’s advice for emerging leaders on career growth and maintaining a patient-first focus.
To Learn More About Our Guest And Their Company:
LinkedIn https://www.linkedin.com/in/joerg-ahlgrimm-315a925/
Company LinkedIn https://www.linkedin.com/company/skpharmteco/
Website https://www.skpharmteco.com/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/
BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/
Aucun commentaire pour le moment